AGM AND TOUR OF FACILITY The Magellan Stem Cells Annual General Meeting of was held in December at the Braeside premises where Magellan Chair, Lou Panaccio conducted a fruitful meeting for those in attendance and those online. Several investors joined us after the meeting for a tour of the impressive new facility which was well […]
Magellan are pleased to announce the results of our Phase 1/2 allogenic trial. The research findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI), which publishes the evidence-based, international consensus guidelines on osteoarthritis management.
Australian Health Minister announced a $7 million grant to Magellan Stem Cells – read more here
Should you want further information regarding our results or media release please email info@magellanstemcells.com.au or call 03 9270 8080.
